GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medios AG (LTS:0QB4) » Definitions » Institutional Ownership

Medios AG (LTS:0QB4) Institutional Ownership : 29.84% (As of Jun. 24, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Medios AG Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medios AG's institutional ownership is 29.84%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medios AG's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medios AG's Float Percentage Of Total Shares Outstanding is 0.00%.


Medios AG Institutional Ownership Historical Data

The historical data trend for Medios AG's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medios AG Institutional Ownership Chart

Medios AG Historical Data

The historical data trend for Medios AG can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 31.58 31.50 31.07 30.24 31.36 31.42 31.08 30.34 29.75 29.84

Medios AG Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Medios AG (LTS:0QB4) Business Description

Address
Friedrichstrasse 113a, Berlin, DEU, 10117
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes provision of medicinal products which focuses on pharmaceutical medicinal products; Patient-specific therapies comprise the manufacture of medications.

Medios AG (LTS:0QB4) Headlines

No Headlines